CP-64434 水和物
CP-64434 水和物 物理性質
- 沸点 :
- 821.4±65.0 °C(Predicted)
- 比重(密度) :
- 1.18±0.1 g/cm3(Predicted)
- 貯蔵温度 :
- room temp
- 溶解性:
- DMSO：10mg/mL以上
- 酸解離定数(Pka):
- 13.28±0.70(Predicted)
- 外見 :
- 粉
- 色:
- ホワイトからオフホワイト
- 安定性：:
- Hygroscopic
安全性情報
- リスクと安全性に関する声明
- 危険有害性情報のコード(GHS)
| 絵表示（GHS） |
|
| 注意喚起語 |
警告 |
| 危険有害性情報 |
| コード |
危険有害性情報 |
危険有害性クラス |
区分 |
注意喚起語 |
シンボル |
P コード |
| H302 |
飲み込むと有害 |
急性毒性、経口 |
4 |
警告 |
|
P264, P270, P301+P312, P330, P501 |
| H315 |
皮膚刺激 |
皮膚腐食性/刺激性 |
2 |
警告 |
|
P264, P280, P302+P352, P321,P332+P313, P362 |
| H319 |
強い眼刺激 |
眼に対する重篤な損傷性/眼刺激 性 |
2A |
警告 |
|
P264, P280, P305+P351+P338,P337+P313P |
| H335 |
呼吸器への刺激のおそれ |
特定標的臓器毒性、単回暴露； 気道刺激性 |
3 |
警告 |
|
|
|
| 注意書き |
| P261 |
粉じん/煙/ガス/ミスト/蒸気/スプレーの吸入を避ける こと。 |
| P305+P351+P338 |
眼に入った場合：水で数分間注意深く洗うこと。次にコ ンタクトレンズを着用していて容易に外せる場合は外す こと。その後も洗浄を続けること。 |
|
CP-64434 水和物 価格
もっと(9)
| メーカー |
製品番号 |
製品説明 |
CAS番号 |
包装 |
価格 |
更新時間 |
購入 |
|
富士フイルム和光純薬株式会社(wako)
|
W01TRCD291000 |
N'-Desmethyl Azithromycin |
172617-84-4 |
10mg |
￥30000 |
2024-03-01 |
購入 |
|
富士フイルム和光純薬株式会社(wako)
|
W01TRCD291000 |
N'-Desmethyl Azithromycin |
172617-84-4 |
25mg |
￥58800 |
2024-03-01 |
購入 |
|
Sigma-Aldrich Japan
|
PZ0130 |
CP-64434 水和物 ≥98% (HPLC)
CP-64434 hydrate ≥98% (HPLC) |
172617-84-4 |
5mg |
￥20200 |
2024-03-01 |
購入 |
|
富士フイルム和光純薬株式会社(wako)
|
PHR3759 |
N-Demethylazithromycin certified reference material, pharmaceutical secondary standard
certified reference material, pharmaceutical secondary standard |
172617-84-4 |
50MG |
￥92600 |
2024-03-01 |
購入 |
|
Sigma-Aldrich Japan
|
1046089 |
United States Pharmacopeia (USP) Reference Standard
N-Demethylazithromycin United States Pharmacopeia (USP) Reference Standard |
172617-84-4 |
15mg |
￥194000 |
2024-03-01 |
購入 |
CP-64434 水和物 化学特性,用途語,生産方法
化学的特性
White Solid
CP-64434 水和物 上流と下流の製品情報
原材料
準備製品
CP-64434 水和物 生産企業
Global( 92)Suppliers
172617-84-4(CP-64434 水和物)キーワード:
- 172617-84-4
- (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-[(2,6-dideoxy-3-C-Methyl-3-O-Methyl-α-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptaMethyl-11-[[3,4,6-trideoxy-3-(MethylaMino)-β-D-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopentadecan-15-one
- CP-64434
- N-DesMethyl AzithroMycin (IMpurity I)
- 3′-N-Desmethylazithromycin
- CP-64434 hydrate
- N′-Desmethylazithromycin hydrate
- (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-
trihydroxy-13-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-
dimethyltetrahydro-2H-pyran-2-yl)oxy)-11-(((2R,3R,4S,6R)-
3-hydroxy-6-methyl-4-(methylamino)tetrahydro-2H-pyran-2-
yl)oxy)-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-
15-one
- (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)‐2‐ethyl‐3,4,10‐trihydroxy‐13‐{(2R,4R,5S,6S)‐5‐hydroxy‐4‐methoxy‐4,6‐dimethyl-tetrahydropyran‐2‐yloxy}‐11‐{(2S,3R,4S,6R)‐3‐hydroxy‐6‐methyl‐4‐methylamino-tetrahydropyran‐2‐yloxy}‐3,5,6,8,10,12,14‐heptamethyl‐1‐oxa‐6‐azacyclopentadecan‐15‐one
- (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-[[3,4,6-trideoxy-3-(methylamino)
- Azithromycin Impurit Ⅳ：( Impurit I)N'-Desmethyl Azithromycin
- Azithromycin EP Impurity I(USP)
- (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-11-[(2S,3R,4S,6R)-3-hydroxy-6-methyl-4-(methylamino)oxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one
- (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10- trihydroxy-13-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6- dimethyltetrahydro-2H-pyran-2-yl)oxy)-11-(((2R,3R,4S,6R)- 3-hydroxy-6-methyl-4-(methylamino)tetrahydro-2H-pyran-2- yl)oxy)-3,5,6,8,10,12,14-heptame
- Azithromycin EP Imp I
- Azithromycin-4
- Azithromycin EP Impurity I/(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-13-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-11-(((2S,3R,4S,6R)-3-hydroxy-6-methyl-4-(methylamino)tetrahydro-2H-pyran-2-yl)oxy)-3
- Azithromycin Impurity 9（Azithromycin EP Impurity I）
- (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-13-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-11-(((2R,3R,4S,6R)-3-hydroxy-6-methyl-4(methylamino)tetrahydro -2H-pyran-2-yl)oxy)-3,5,6,8,10,12,14-heptamethyl
- Azithromycin EP Impurity I (N-Desmethyl Azithromycin)
- Na€-Desmethyl Azithromycin
- Azithromycin Impurity I(N-Desmethyl Azithromycin)
- Azithromycin Impurity I(BP)
- N-Demethylazithromycin (USP)
- 3′-N-Demethyl Azithromycin
- 1-Oxa-6-azacyclopentadecan-15-one, 13-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-[[3,4,6-trideoxy-3-(methylamino)-β-D-xylo-hexopyranosyl]oxy]-, (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-
- USP N-Demethylazithromycin
- Azithromycin EP Impurity I/ N-Demethylazithromycin (3′-N-Demethyl Azithromycin)
- Azithromycin EP impurity IQ: What is
Azithromycin EP impurity I Q: What is the CAS Number of
Azithromycin EP impurity I Q: What is the storage condition of
Azithromycin EP impurity I Q: What are the applications of
Azithromycin EP impurity I
- N-Demethylazithromycin
- Azithromycin BP Impurity-I
- CP-64434 水和物